Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library

International Journal of Molecular Medicine

Volumn 19, Issue 5, 2007, Pages 829-839

  Horwacik, Irena ^a   Czaplicki, Dominik ^a   Talarek, Katarzyna ^a   Kowalczyk, Aleksandra ^a   Bolesta, Elzbieta ^b   Kozbor, Danuta ^b   Rokita, Hanna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

14G2a mAb; GD2 ganglioside; Peptide mimics; Phage displayed peptide library

Indexed keywords

DISULFIDE; GANGLIOSIDE; GANGLIOSIDE, GD2; MONOCLONAL ANTIBODY; PEPTIDE; PEPTIDE LIBRARY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING COMPETITION; CELL CLONE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MOLECULAR MIMICRY; NEUROBLASTOMA; PATHOLOGY; PROTEIN BINDING; SEQUENCE ANALYSIS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; CELL LINE, TUMOR; CLONE CELLS; DISULFIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIOSIDES; HUMANS; IMMUNOBLOTTING; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; SEQUENCE ANALYSIS, PROTEIN;

EID: 34248561406     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.5.829     Document Type: Article

References (45)

1. Varki A: Glycosylation changes in cancer. In: Essentials of Glycobiology. Varki A, Cummings R, Esko R, Freeze H, Hart G and Marth J (ed). Cold Spring Harbor Laboratory Press, New York, pp537-549, 1999.
2. Livingston PO, Zhang S and Lloyd KO: Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale. Cancer Immunol Immunother 45: 1-9, 1997.
3. Birkle S, Zeng G, Gao L, Yu RK and Aubry J: Role of tumor-associated gangliosides in cancer progression. Biochimie 85: 455-463, 2003.
4. Hettmer S, Malott C, Woods W, Ladisch S and Kaucic K: Biological stratification of human neuroblastoma by complex "B" pathway ganglioside expression. Cancer Res 63: 7270-7276, 2003.
5. Hettmer S, McCarter R, Ladisch S and Kaucic K: Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid. Br J Cancer 91: 389-397, 2004.
6. Valentino L, Moss T, Olson E, Wang HJ, Elashoff R and Ladisch S: Shed tumor gangliosides and progression of human neuroblastoma. Blood 75: 1564-1567, 1990.
7. Ruan S, Raj BK and Lloyd KO: Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells. J Neurochem 72: 514-521, 1999.
8. Yoshida S, Fukumoto S, Kawaguchi H, Sato S, Ueda R and Furukawa K: Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res 61: 4244-4252, 2001.
9. Shurin GV, Shurin MR, Bykovskaia S, Shogan J, Lotze MT and Barksdale EM Jr: Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 61: 363-369, 2001.
10. Ravindranath MH and Morton DL: Antigens: carbohydrates. In: Encyclopedia of life sciences. Nature Publishing Group. www.els.net, 2001.
11. Wu ZL, Schwartz E, Seeger R and Ladisch S: Expression of GD2 ganglioside by untreated primary human neuroblastomas. Cancer Res 46: 440-443, 1986.
12. Reuland P, Geiger L, Thelen MH, Handgretinger R, Haase B, Muller-Schauenburg W, Niethammer D and Bares R: Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response. J Pediatr Hematol Oncol 23: 437-442, 2001.
13. Beiske K, Ambros PF, Burchill SA, Cheung IY and Swerts K: Detecting minimal residual disease in neuroblastoma patients - the present state of the art. Cancer Lett 228: 229-240, 2005.
14. Kramer K, Gerald WL, Kushner BH, Larson SM, Hameed M and Cheung NK: Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. Med Pediatr Oncol 36: 194-196, 2001.
15. Cheung NK, Kushner BH and Kramer K: Monoclonal antibody-based therapy of neuroblastoma. Hematol Oncol Clin North Am 15: 853-866, 2001.
16. Fredman P, Hedberg K and Brezicka T: Gangliosides as therapeutic targets for cancer. BioDrugs 17: 155-167, 2003.
17. Smith GP and Petrenko VA: Phage display. Chem Rev 97: 391-410, 1997.
18. Ashok BT, David L, Chen YG, Garikapaty VP, Chander B, Kanduc D, Mittelman A and Tiwari RK: Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer. Int J Mol Med 11: 465-471, 2003.
19. Zhang H, Zhong Z and Pirofski LA: Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Infect Immun 65: 1158-1164, 1997.
20. Fleuridor R, Lees A and Pirofski LA: A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J Immunol 166: 1087-1096, 2001.
21. Kieber-Emmons T, Monzavi-Karbassi B, Wang B, Luo P and Weiner DB: Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response. J Immunol 165: 623-627, 2000.
22. Bonnycastle LL, Mehroke JS, Rashed M, Gong X and Scott JK: Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage. J Mol Biol 258: 747-762, 1996.
23. Way JC, Davis MA, Morisato D, Roberts DE and Kleckner N: New Tn10 derivatives for transposon mutagenesis and for construction of lacZ operon fusions by transposition. Gene 32: 369-379, 1984.
24. Murray JL, Cunningham JE, Brewer H, Mujoo K, Zukiwski AA, Podoloff DA, Kasi LP, Bhadkamkar V, Fritsche HA and Benjamin RS: Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors. J Clin Oncol 12: 184-193, 1994.
25. Mendez A, Bonnycastle LL, Pan OC and Scott JK: Screening peptide libraries. In: Phage display. A laboratory manual. Barbas CF, Burton DR, Scott JK and Silverman GJ (eds). Cold Spring Harbor Laboratory Press, New York, pp17.8-17.11, 2001.
26. Tumilowicz JJ, Nichols WW, Cholon JJ and Greene AE: Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30: 2110-2118, 1970.
27. Hettmer S, Ladisch S and Kaucic K: Low complex ganglioside expression characterizes human neuroblastoma cell lines. Cancer Lett 225: 141-149, 2005.
28. Bonnycastle LL, Mendez A and Scott JK: General phage methods. In: Phage display. A laboratory manual. Barbas CF, Burton DR, Scott JK and Silverman GJ (eds). Cold Spring Harbor Laboratory Press, New York, pp15.5-15.17, 2001.
29. Bolesta E, Kowalczyk A, Wierzbicki A, Rotkiewicz P, Bambach B, Tsao CY, Horwacik I, Kolinski A, Rokita H, Brecher M, Wang X, Ferrone S and Kozbor D: DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses. Cancer Res 65: 3410-3418, 2005.
30. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG and Thompson JD: Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31: 3497-3500, 2003.
31. Kropelin M, Susal C, Daniel V and Opelz G: Inhibition of HIV-1 rgp120 binding to CD4+ T cells by monoclonal antibodies directed against the gp120 C1 or C4 region. Immunol Lett 63: 19-25, 1998.
32. Balass M, Katchalski-Katzir E and Fuchs S: The alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor: analysis using a phage-epitope library. Proc Natl Acad Sci USA 94: 6054-6058, 1997.
33. Sibille P and Strosberg AD: A FIV epitope defined by a phage peptide library screened with a monoclonal anti-FIV antibody. Immunol Lett 59: 133-137, 1997.
34. Valadon P, Nussbaum G, Boyd LF, Margulies DH and Scharff MD: Peptide libraries define the fine specificity of antipolysaccharide antibodies to Cryptococcus neoformans. J Mol Biol 261: 11-22, 1996.
35. Johnson DL, Farrell FX, Barbone FP, McMahon FJ, Tullai J, Hoey K, Livnah O, Wrighton NC, Middleton SA, Loughney DA, Stura EA, Dower WJ, Mulcahy LS, Wilson IA and Jolliffe LK: Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry 37: 3699-3710, 1998.
36. Forster-Waldl E, Riemer AB, Dehof AK, Neumann D, Bramswig K, Boltz-Nitulescu G, Pehamberger H, Zielinski CC, Scheiner O, Pollak A, Lode H and Jensen-Jarolim E: Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen. Mol Immunol 42: 319-325, 2005.
37. Beninati C and Teti G: A meeting of mimics. Trends Microbiol 8: 492-493, 2000.
38. Willers J, Lucchese A, Kanduc D and Ferrone S: Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside. Peptides 20: 1021-1026, 1999.
39. Luo P, Agadjanyan M, Qiu J, Westerink MA, Steplewski MAJ and Kieber-Emmons T: Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens. Mol Immunol 35: 865-879, 1998.
40. Monzavi-Karbassi B, Shamloo S, Kieber-Emmons M, Jousheghany F, Luo P, Lin KY, Cunto-Amesty G, Weiner DB and Kieber-Emmons T: Priming characteristic of peptide mimotopes of carbohydrate antigens. Vaccine 21: 753-760, 2003.
41. Riemer AB, Forster-Waldl E, Bramswig KH, Pollak A, Zielinski CC, Pehamberger H, Lode HN, Scheiner O and Jensen-Jarolim E: Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes. Eur J Immunol 36: 1267-1274, 2006.
42. Chapman PB, Morrisey D, Panageas KS, Williams L, Lewis JJ, Israel RJ, Hamilton WB and Livingston PO: Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyanin. Clin Cancer Res 6: 4658-4662, 2000.
43. Foon KA, Lutzky J, Baral RN, Yannelli JR, Hutchins L, Teitelbaum A, Kashala OL, Das R, Garrison J, Reisfeld RA and Bhattacharya-Chatterjee M: Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. J Clin Oncol 118: 376-384, 2000.
44. Uttenreuther-Fischer MM, Kruger JA and Fischer P: Molecular characterization of the anti-idiotypic immune response of a relapse-free neuroblastoma patient following antibody therapy: a possible vaccine against tumors of neuroectodermal origin? (erratum in J Immunol 177: 2738, 2006) J Immunol 176: 7775-7786, 2006.
45. Cheung NK, Guo HF, Heller G and Cheung IY: Induction of Ab3 and Ab3′ antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma. Clin Cancer Res 6: 2653-2660, 2000.